DHR US EQUITY Health Care Life Sciences Tools & Services CIK: 313616

Danaher Corporation (DHR) Quant Factor Diagnostic & Fair Value Model

Danaher Corporation (Ticker: DHR) is listed in the Health Care sector (Life Sciences Tools & Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$230.50

+0.33% Latest Close (2026-10-23)

Market Cap: $157.48B

P/E Ratio: 46.9

Momentum Strength 3M / 12M

+17.30%

1M: +3.01% 12M: +5.69%

Quality (ROE) Point-in-Time

Trailing Return on Equity

Technical Trend RSI 14

60.3

SMA50: $216.13 SMA200: $201.20

Valuation Multiplier Trailing

46.9

Premium Multiple (> 30x P/E)

📊 Valuation & Multi-Factor Diagnostic

Premium Multiple (> 30x P/E)

DHR trades at 46.9x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线多头 (MA20/50) Piotroski F-Score: 5/9 (Moderate Financial Health)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 313616 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
10-Q	2026-06-26	2026-07-21	-	$870.00M	$2.86B	$1.23
10-Q	2025-12-31	2026-07-21	-	-	-	-
10-Q	2025-06-27	2026-07-21	-	$555.00M	$2.64B	$0.77
10-Q	2026-03-27	2026-04-21	-	$1.03B	$1.32B	$1.45
10-Q	2025-03-28	2026-04-21	-	$954.00M	$1.30B	$1.32
10-K	2025-12-31	2026-02-24	-	$3.61B	$6.42B	$5.05
10-K	2024-12-31	2026-02-24	-	$3.90B	$6.69B	$5.29
10-K	2023-12-31	2026-02-24	-	$4.76B	$7.16B	$1.45

💡 Methodology & Frequently Asked Questions

Key reference details regarding Danaher Corporation (DHR) valuation multiples, momentum factors, and point-in-time filing conventions.

How should DHR's current valuation multiple be interpreted? ↓

DHR trades at a trailing P/E of 46.9x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are DHR's key momentum and technical factor indicators? ↓

As of the latest close, DHR shows a 1-month return of +3.01%, 3-month return of +17.30%, and 12-month return of +5.69%, with a 14-day RSI of 60.3. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for DHR? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can DHR be incorporated into systematic factor models? ↓

DHR can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.